NLRP3 and ischemic stroke: These results indicate that LIGc markedly suppresses the inflammatory response in the cerebral cortex of mice with neuroinflammation and ischemic stroke by modulating the FPR1/NLRP3 signaling pathway, thereby ameliorating their neurological deficits and disease progression.